Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury
Authors:
- Vikas MishraVMVikas Mishra
- Ram RaghubirRRRam Raghubir
- 1 July 2010
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 638 (1-3) , 65-71
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Identification of Ischemic Regions in a Rat Model of StrokePLOS ONE, 2009
- Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human AstrocytesJournal of Biological Chemistry, 2008
- The role of glutamate transporters in neurodegenerative diseases and potential opportunities for interventionNeurochemistry International, 2007
- Neuroprotective potential of ceftriaxone in in vitro models of strokeNeuroscience, 2007
- Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) UpregulationStroke, 2007
- Volume-Regulated Anion Channels Are the Predominant Contributors to Release of Excitatory Amino Acids in the Ischemic Cortical PenumbraStroke, 2004
- Mechanisms of Motor Dysfunction After Transient MCA Occlusion: Persistent Transmission Failure in Cortical Synapses Is a Major DeterminantStroke, 1998
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.Stroke, 1986
- Present status and significance of the glutamine cycle in neural tissuesLife Sciences, 1981